Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026)

Cresco Labs' (CRLBF) quarterly Income from Non-Controlling Interests came in at -$3.9 million in Q1 2026, down 391.52% YoY from $1.4 million in Q1 2025, and down 189.64% on a QoQ basis from -$1.4 million in Q4 2025.

Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Income from Non-Controlling Interests data on file, last reported at -$3.9 million in Q1 2026.

  • Quarterly Income from Non-Controlling Interests fell 391.52% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 177.69% YoY) and the FY2025 annual result came in at -$4.6 million, down 133.24% from the prior year.
  • Income from Non-Controlling Interests slipped to -$3.9 million in Q1 2026, from -$1.4 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $6.5 million in Q3 2022 to a low of -$19.3 million in Q4 2022.
  • A 5-year average of -$162058.8 and a median of $2.2 million in 2023 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests slumped 783.66% — and 2024, when it surged 278.19%.
  • Tracing CRLBF's Income from Non-Controlling Interests over 5 years: stood at -$19.3 million in 2022, then soared by 111.58% to $2.2 million in 2023, then surged by 115.45% to $4.8 million in 2024, then tumbled by 128.29% to -$1.4 million in 2025, then sank by 189.64% to -$3.9 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$3.9 million (Q1 2026), -$1.4 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn -
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Cresco Labs 297.83 Mn 233.72 Mn 86.95 Mn -1.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.94 Mn
Dec 31, 2025 -1.36 Mn
Sep 30, 2025 -4.91 Mn
Jun 30, 2025 2.44 Mn
Mar 31, 2025 -802,000.00
Dec 31, 2024 4.81 Mn
Sep 30, 2024 2.85 Mn
Jun 30, 2024 3.15 Mn
Mar 31, 2024 3.14 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 -6.93 Mn
Mar 31, 2023 -1.76 Mn
Dec 31, 2022 -19.29 Mn
Sep 30, 2022 6.54 Mn
Jun 30, 2022 5.25 Mn
Mar 31, 2022 3.71 Mn
Dec 31, 2021 2.82 Mn
Sep 30, 2021 7.19 Mn
Jun 30, 2021 7.48 Mn